Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 809

1.

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.

Ahrendt SA, Hu Y, Buta M, McDermott MP, Benoit N, Yang SC, Wu L, Sidransky D.

J Natl Cancer Inst. 2003 Jul 2;95(13):961-70.

PMID:
12837832
[PubMed - indexed for MEDLINE]
Free Article
2.

Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.

Mitsudomi T, Oyama T, Kusano T, Osaki T, Nakanishi R, Shirakusa T.

J Natl Cancer Inst. 1993 Dec 15;85(24):2018-23.

PMID:
8246288
[PubMed - indexed for MEDLINE]
3.

Implications and prognostic value of K-ras mutation for early-stage lung cancer in women.

Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT.

J Natl Cancer Inst. 1999 Dec 1;91(23):2032-8.

PMID:
10580029
[PubMed - indexed for MEDLINE]
Free Article
4.

Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.

Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.

Oncogene. 1998 May 14;16(19):2469-77.

PMID:
9627113
[PubMed - indexed for MEDLINE]
Free Article
5.

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.

Xu HJ, Quinlan DC, Davidson AG, Hu SX, Summers CL, Li J, Benedict WF.

J Natl Cancer Inst. 1994 May 4;86(9):695-9.

PMID:
8158700
[PubMed - indexed for MEDLINE]
6.

p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients.

Skaug V, Ryberg D, Kure EH, Arab MO, Stangeland L, Myking AO, Haugen A.

Clin Cancer Res. 2000 Mar;6(3):1031-7.

PMID:
10741731
[PubMed - indexed for MEDLINE]
Free Article
7.

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.

Schiller JH, Adak S, Feins RH, Keller SM, Fry WA, Livingston RB, Hammond ME, Wolf B, Sabatini L, Jett J, Kohman L, Johnson DH.

J Clin Oncol. 2001 Jan 15;19(2):448-57.

PMID:
11208838
[PubMed - indexed for MEDLINE]
8.

Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).

Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P.

J Thorac Oncol. 2009 Jan;4(1):12-21. doi: 10.1097/JTO.0b013e3181913e28.

PMID:
19096301
[PubMed - indexed for MEDLINE]
9.

p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients.

Murakami I, Hiyama K, Ishioka S, Yamakido M, Kasagi F, Yokosaki Y.

Clin Cancer Res. 2000 Feb;6(2):526-30.

PMID:
10690534
[PubMed - indexed for MEDLINE]
Free Article
10.

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.

Ahrendt SA, Yang SC, Wu L, Roig CM, Russell P, Westra WH, Jen J, Brock MV, Heitmiller RF, Sidransky D.

J Thorac Cardiovasc Surg. 2002 Mar;123(3):466-73; discussion 473-4.

PMID:
11882817
[PubMed - indexed for MEDLINE]
11.

p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland.

Niklinska W, Burzykowski T, Chyczewski L, Rusin MR, Furman M, Laudanski J, Chyczewska E, Sulik M, Niklinski J.

Eur J Cancer Prev. 2000 Apr;9(2):81-7.

PMID:
10830574
[PubMed - indexed for MEDLINE]
12.

Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Piattoni S, Di Carlo L, Semeraro A, Darwish S, Tofanetti FR, Stocchi L, Mihaylova Z, Bellezza G, Del Sordo R, Daddi G, Crinò L, Tonato M.

J Thorac Oncol. 2008 Apr;3(4):365-73. doi: 10.1097/JTO.0b013e318168c7d0.

PMID:
18379354
[PubMed - indexed for MEDLINE]
13.

A study of smoking, p53 tumor suppressor gene alterations and non-small cell lung cancer.

Tammemagi MC, McLaughlin JR, Mullen JB, Bull SB, Johnston MR, Tsao MS, Casson AG.

Ann Epidemiol. 2000 Apr;10(3):176-85.

PMID:
10813511
[PubMed - indexed for MEDLINE]
14.

Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.

Huang CL, Taki T, Adachi M, Konishi T, Higashiyama M, Kinoshita M, Hadama T, Miyake M.

Int J Oncol. 1998 Mar;12(3):553-63.

PMID:
9472092
[PubMed - indexed for MEDLINE]
15.

Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis.

Niklińska W, Burzykowski T, Chyczewski L, Nikliński J.

Lung Cancer. 2001 Dec;34 Suppl 2:S59-64.

PMID:
11720743
[PubMed - indexed for MEDLINE]
16.

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.

Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003. Epub 2008 Jul 11.

PMID:
18620780
[PubMed - indexed for MEDLINE]
17.

A novel molecular staging protocol for non-small cell lung cancer.

Miyake M, Adachi M, Huang C, Higashiyama M, Kodama K, Taki T.

Oncogene. 1999 Apr 8;18(14):2397-404.

PMID:
10327061
[PubMed - indexed for MEDLINE]
Free Article
18.

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

Apolinario RM, van der Valk P, de Jong JS, Deville W, van Ark-Otte J, Dingemans AM, van Mourik JC, Postmus PE, Pinedo HM, Giaccone G.

J Clin Oncol. 1997 Jun;15(6):2456-66.

PMID:
9196162
[PubMed - indexed for MEDLINE]
19.

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.

Tsao MS, Aviel-Ronen S, Ding K, Lau D, Liu N, Sakurada A, Whitehead M, Zhu CQ, Livingston R, Johnson DH, Rigas J, Seymour L, Winton T, Shepherd FA.

J Clin Oncol. 2007 Nov 20;25(33):5240-7.

PMID:
18024870
[PubMed - indexed for MEDLINE]
20.

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.

Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K, Kawakami Y.

Cancer. 1995 Dec 15;76(12):2457-63.

PMID:
8625071
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk